Axonia Medical Acquires 51% Stake in Dipylon Medical in Strategic Move to Scale Global Molecular Diagnostics Platform
Backed by strong diagnostics market growth and industry consolidation, the transaction positions Axonia Medical to expand across PCR, microbiology, and laboratory automation segments
SINGAPORE, SG / ACCESS Newswire / March 26, 2026 / Axonia Medical today announced the acquisition of a 51% controlling stake in Dipylon Medical in a transaction valued at approximately $8 million, including upfront cash consideration and performance-based earnouts tied to revenue growth and geographic expansion.
The acquisition strengthens Axonia Medical's position in the rapidly expanding molecular diagnostics and clinical microbiology market, a sector increasingly viewed as critical to modern healthcare systems.
Diagnostics Market Supported by Strong Structural Growth
The global molecular diagnostics market is projected to grow at a compound annual growth rate (CAGR) of 8%-11% through 2030, driven by increasing demand for PCR testing, infectious disease detection, and precision medicine.
According to industry research from MarketsandMarkets, the molecular diagnostics market is expected to surpass $25 billion by the end of the decade, supported by advancements in genomic technologies and expanded laboratory capacity.
In parallel, Frost & Sullivan reports that clinical microbiology and diagnostics segments are experiencing accelerated adoption due to automation, decentralized testing, and the global focus on early disease detection.
A recent report from McKinsey & Company further highlights diagnostics as one of the fastest-growing areas in healthcare, driven by investments in molecular testing platforms and laboratory digitalization.
"Diagnostics-particularly molecular testing-has become a core pillar of healthcare delivery, supported by strong demand visibility and scalable business models," said Dr. Robert Mitt, a healthcare analyst at a leading global investment firm.
Strategic Expansion into High-Value Diagnostic Technologies
Dipylon Medical provides specialized laboratory equipment across key diagnostic categories, including:
PCR Thermocyclers
DNA & RNA Purification Systems
Hematology Analyzers
The company distributes solutions from globally recognized manufacturers such as Thermo Fisher Scientific, Bio-Rad Laboratories, and Roche Diagnostics, serving hospitals, research laboratories, and diagnostic centers.
"Dipylon Medical brings immediate scale and credibility in the diagnostics supply chain," said Sarah Lee, a spokesperson for Axonia Medical. "This acquisition allows us to expand our platform into high-growth molecular diagnostics while strengthening our global distribution footprint."
About Axonia Medical
Axonia Medical is a healthcare-focused organization dedicated to investing in and scaling advanced medical technologies across diagnostics, laboratory equipment, and healthcare infrastructure.
Learn more:
https://axoniamedical.com/content/4-about-us
About Dipylon Medical
Dipylon Medical is a supplier of clinical microbiology and laboratory diagnostic equipment, specializing in molecular biology technologies including PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers.
Learn more:
https://dipylonmedical.com/about/
Media Contact
Kim Lee
Public Relation Manager
Dipylon Medical
+1812-768-6999
Email: [email protected]
Website: https://dipylonmedical.com/
SOURCE: dipylonmedical